Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jun;170(6):709-18.
doi: 10.1007/s00431-010-1319-z. Epub 2010 Oct 8.

Inhaled corticosteroids in childhood asthma: the story continues

Wim M C van Aalderen  1 , Aline B Sprikkelman
Affiliations
Review

Inhaled corticosteroids in childhood asthma: the story continues

Wim M C van Aalderen et al. Eur J Pediatr. 2011 Jun.

Abstract

Inhaled corticosteroids (ICS) are the most effective anti-inflammatory drugs for the treatment of persistent asthma in children. Treatment with ICS decreases asthma mortality and morbidity, reduces symptoms, improves lung function, reduces bronchial hyperresponsiveness and reduces the number of exacerbations. The efficacy of ICS in preschool wheezing is controversial. A recent task force from the European Respiratory Society on preschool wheeze defined two different phenotypes: episodic viral wheeze, wheeze that occurs only during respiratory viral infections, and multiple-trigger wheeze, where wheeze also occurs in between viral episodes. Treatment with ICS appears to be more efficacious in the latter phenotype. Small particle ICS may offer a potential benefit in preschool children because of the favourable spray characteristics. However, the efficacy of small particle ICS in preschool children has not yet been evaluated in prospective clinical trials. The use of ICS in school children with asthma is safe with regard to systemic side effects on the hypothalamic-pituitary-adrenal axis, growth and bone metabolism, when used in low to medium doses. Although safety data in wheezing preschoolers is limited, the data are reassuring. Also for this age group, adverse events tend to be minimal when the ICS is used in appropriate doses.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Gina guidelines for children 5 years and younger
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adams NP, Bestall JC, Jones PW (1999) Budesonide versus placebo for chronic asthma in children and adults. In: The Cochrane library, issue 4. Wiley, Chichester
    1. Adams NP, Bestall JC, Malouf R et al (2005a) Beclomethasone versus placebo for chronic asthma. Cochrane Database Syst Rev (1):CD002738 - PMC - PubMed
    1. Adams NP, Bestall JC, Lasserson TJ et al (2005b) Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database Syst Rev (4):CD003135 - PubMed
    1. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000;343:1064–1069. doi: 10.1056/NEJM200010123431502. - DOI - PubMed
    1. Allen DB. Safety of inhaled corticosteroids in children. Pediatr Pulmonol. 2002;33:208–220. doi: 10.1002/ppul.10040. - DOI - PubMed

MeSH terms

Substances